Tag: MORPHOSYS AG

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to MORPHOSYS AG

German biotechnology company MorphoSys acquires US rival for $ 1.7 billion

Added to Collection on: 2021-06-02 18:00:00

Tags for this article:

Life Sciences
Companies
Biotechnology companies
MorphoSys
AstraZeneca
royalty pharma
Pharmaceutical industry in India
MORPHOSYS AG
United States

Click the tags to see associated articles and topics

View Article Details
MorphoSys' Partner Incyte Announced Development and Commercialization Agreement ...

Added to Collection on: 2021-08-17 06:33:45

Tags for this article:

Drugs
MorphoSys
Health care
Monoclonal antibodies
Incyte
Orphan drugs
Tafasitamab
Lymphoma
Non-Hodgkin lymphoma
Diffuse large B-cell lymphoma
Lenalidomide
MorphoSys Group
MORPHOSYS AG

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D ...

Added to Collection on: 2021-10-07 12:22:30

Tags for this article:

Life Sciences
Companies
Biotechnology companies
Economy of New York City
NASDAQ
Amgen
MorphoSys
Vertex Pharmaceuticals
Pluristem Therapeutics
PTC Therapeutics
ensysce biosciences, inc.
DURECT Corporation
Indaptus Therapeutics Inc.
Aziyo Biologics Inc.
eiger biopharmaceuticals inc
Minerva Neurosciences Inc
Aytu BioPharma Inc.
Orphazyme A/S
ROCKWELL MEDICAL , INC
Glaukos Corporation
Heron Therapeutics Inc
Longeveron Inc.
HCW Biologics Inc.
Catalyst Pharmaceuticals Inc
Hoth Therapeutics Inc.
DICE Therapeutics, Inc.
TELIGENT , INC
Aptinyx Inc.
Nuwellis Inc.
Adverum Biotechnologies Inc.
BiondVax Pharmaceuticals Ltd.
Spruce Biosciences Inc.
Mesoblast Limited
Chemomab Therapeutics, Ltd.
Kiniksa Pharmaceuticals Ltd
trevi therapeutics, inc.
Black Diamond Therapeutics, Inc.
Avenue Therapeutics Inc.
China SXT Pharmaceuticals Inc.
Amgen Inc.
POINT Biopharma Global Inc.
TCR2 Therapeutics Inc.
Pluristem Therapeutics Inc.
Forte Biosciences Inc.
Vertex Pharmaceuticals Incorporated
Oncorus Inc.
Year Moderna, Inc.
Acutus Medical Inc.
Neovasc Inc.
Spectrum Pharmaceuticals Inc.
Oyster Point Pharma Inc.
Incyte Corporation
Moleculin Biotech Inc.
Nautilus Biotechnology Inc.
Caladrius Biosciences Inc.
MORPHOSYS AG
Inhibikase Therapeutics Inc.
Galecto Inc.
MaxCyte Inc.
Immunic Inc
Kiromic BioPharma Inc.
Cellectis SA
Gamida Cell Ltd
BioSig Technologies Inc.
LumiraDx Limited
NRx Pharmaceuticals, Inc.
Stoke Therapeutics Inc
histogen inc
Calliditas Therapeutics AB
PTC Therapeutics Inc.
Solid Biosciences Inc.
Aravive Inc
Titan Pharmaceuticals Inc.
Roivant Sciences Ltd.
Liminal BioSciences Inc.
Akoya Biosciences Inc.
Kaleido Biosciences Inc.
Applied Genetic Technologies Corporation
Moderna
Assertio Holdings Inc.
Talis Biomedical Corporation
Sangamo Therapeutics Inc.
Lixte Biotechnology Holdings Inc.
Petros Pharmaceuticals Inc.
KALA PHARMACEUTICALS, INC
XBiotech Inc.
Orchard Therapeutics plc
Legend Biotech Corporation
Galapagos NV
Angion Biomedica Corp
Applied Dna Sciences Inc.
Esperion Therapeutics Inc.
Imara Inc.
Enanta Pharmaceuticals Inc.
Harpoon Therapeutics Inc.
Graphite Bio Inc.
Tiziana Life Sciences PLC
BioVie Inc
Applied Molecular Transport Inc.
Viveve Medical Inc.
Immuron Limited
Protara Therapeutics Inc.
4d molecular therapeutics
HOOKIPA Pharma Inc.
Pasithea Therapeutics Corp.
CASI PHARMACEUTICALS , INC
InMed Pharmaceuticals Inc.
Gain Therapeutics Inc.
NeuroBo Pharmaceuticals Inc.
Opiant Pharmaceuticals Inc
Lipocine Inc

Click the tags to see associated articles and topics

View Article Details
MorphoSys AG (NASDAQ:MOR) Receives Average Recommendation of "Hold" from Analysts

Added to Collection on: 2021-10-09 05:48:32

Tags for this article:

Finance
Money
Financial markets
Stock market
MorphoSys
Short
Price?earnings ratio
Stock
Financial analyst
Technical analysis
MORPHOSYS AG

Click the tags to see associated articles and topics

View Article Details
MorphoSys' Licensing Partner Roche Received Breakthrough Therapy Designation for ...

Added to Collection on: 2021-10-11 06:45:00

Tags for this article:

Branches of biology
Amyloidosis
Biology
MorphoSys
Neuroscience
Alzheimer's disease
Breakthrough therapy
Amyloid beta
MorphoSys Group
MORPHOSYS AG

Click the tags to see associated articles and topics

View Article Details
First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with Immunoglobulin A ...

Added to Collection on: 2021-10-21 09:23:03

Tags for this article:

Medical specialties
Kidney diseases
Clinical medicine
Antibodies
Autoimmune diseases
IgA nephropathy
MorphoSys
Igan
Immunoglobulin A
Membranous glomerulonephritis
Autoantibody
Kidney disease
MorphoSys Group
Munich
MORPHOSYS AG

Click the tags to see associated articles and topics

View Article Details
Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi ...

Added to Collection on: 2022-06-13 20:30:15

Tags for this article:

Drugs
Health care
MorphoSys
Clinical medicine
Orphan drugs
Lymphoma
Non-Hodgkin lymphoma
Immunosuppressants
Antineoplastic drugs
Tafasitamab
Lenalidomide
Incyte
MORPHOSYS AG
United States

Click the tags to see associated articles and topics

View Article Details
Morgan Stanley Increases MorphoSys (NASDAQ:MOR) Price Target to €28.00 | MarketBeat

Added to Collection on: 2022-07-31 09:01:40

Tags for this article:

Finance
Money
Economy
MorphoSys
Stock market
Valuation
Price?earnings ratio
Stock
Short
Financial analyst
MORPHOSYS AG

Click the tags to see associated articles and topics

View Article Details
MorphoSys' Licensing Partner Roche Provides Update on Phase 3 GRADUATE ... - PharmiWeb.com

Added to Collection on: 2022-11-14 06:52:50

Tags for this article:

MorphoSys
Planegg
Forward-looking statement
Pharmaceutical industry in China
Insulin-degrading enzyme
Health
MORPHOSYS AG
Gantenerumab

Click the tags to see associated articles and topics

View Article Details
The Goldman Sachs Group has reduced its rating on MorphoSys (NASDAQ:MOR).

Added to Collection on: 2022-12-17 18:52:45

Tags for this article:

Finance
Money
Economy
MorphoSys
Stock market
Corporate finance
Equity securities
Price?earnings ratio
Financial analyst
Stock
Hedge fund
Securities research
MORPHOSYS AG

Click the tags to see associated articles and topics

View Article Details